4//SEC Filing
aTYR PHARMA INC 4
Accession 0001209191-15-074169
$ATYRCIK 0001339970operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 6:50 PM ET
Size
8.1 KB
Accession
0001209191-15-074169
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blackburn Kelly
See Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2015-10-01+11,581→ 11,581 totalExercise: $10.24→ Common Stock (11,581 underlying) - Award
Employee Stock Option (right to buy)
2015-10-01+45,500→ 45,500 totalExercise: $10.24Exp: 2025-10-01→ Common Stock (45,500 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 1, 2015, such that this option will be fully exercisable on October 1, 2019. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
- [F2]The shares subject to this option shall vest and become exercisable, if at all, in 48 equal monthly installments upon the achievement of certain performance goals, which must be achieved by October 1, 2017, or such option will be subject to immediate forfeiture. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001339970
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 6:50 PM ET
- Size
- 8.1 KB